CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Oncodia is developing RASMAC, a software tool for analyzing cancer DNA sequencing data to improve the accuracy of mutation detection. This project aims to optimize targeted cancer therapies and enhance diagnostic standards in oncology.
As the incidence and prevalence of cancer increases worldwide, advanced anti-cancer drugs have become one of the key cost centres in healthcare budgets.
This is a major societal challenge for the EU and global decision makers.
Nowadays, modern anti-cancer therapies are expensive and are based on mutation analysis of cancer DNA Next-Generation-Sequencing data.
However, state-of-the-art software used to analyse this data lack diagnostic accuracy and regulatory approvals.
Oncodia aims to address th…
ONCODIA AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
